Frequency of common polymorphisms in Caveolin 1 (CAV1) gene in adults with high serum triglycerides from Colombian Caribbean Coast.
Article Sidebar
Main Article Content
Background: Caveolin 1 gene (CAV1) has been associated with insulin resistance, metabolic syndrome and hypertension in humans. Also, it has been related to high serum triglycerides in rodents, however there is little evidence of this relation in humans.
Aim: To describe frequencies of common variations in CAV1 in adults with high serum triglycerides.
Methods: A case-control study was carried out with adults from Colombian Caribbean Coast. A whole blood sample was employed to measure serum concentrations of triglycerides, glucose, total cholesterol and HDLc. Six common Single Nucleotide Polymorphism (SNP) in CAV1 were genotyped (rs926198, rs3779512, rs10270569, rs11773845, rs7804372 and rs1049337). Allelic and genotypic frequencies were determined by direct count and Hardy-Weinberg Equilibrium (HWE) was assessed. Case and control groups were compared with null-hypothesis tests.
Results: A total of 220 cases and 220 controls were included. For rs3779512 an excess in homozygotes frequency was found within case group (40.4% (GG), 41.3% (GT) and 18.1% (TT); Fis=0.13, p=0.03). Another homozygotes excess among case group was found in rs7804372 (59.5% (TT), 32.3% (TA) and 8.2% (AA); Fis=0.12, p=0.04). In rs1049337, cases also showed an excess in homozygotes frequency (52.7% (CC), 35.0% (CT) and 12.3% (TT); Fis=0.16, p=0.01). Finally, for rs1049337 there were differences in genotype distribution between case and control groups (p<0.05).
Conclusion: An increased frequency of homozygote genotypes was found in subjects with high serum triglycerides. This findings suggest that minor alleles for SNPs rs3779512, rs7804372 and rs1049337 might be associated to higher risk of hypertriglyceridemia.
- Hypertriglyceridemia
- Caveolin 1
- Single Nucleotide Polymorphism
- Caribbean Region
- Colombia
- Metabolic diseases
- Triglycerides
Engelman JA, Zhang XL, Lisanti MP. Sequence and detailed organization of the human caveolin-1 and -2 genes located near the D7S522 locus (7q31.1). Methylation of a CpG island in the 5' promoter region of the caveolin-1 gene in human breast cancer cell lines. FEBS Letters. 1999; 448(2-3): 221-30. DOI: https://doi.org/10.1016/S0014-5793(99)00365-8
Glenney JR, Jr. The sequence of human caveolin reveals identity with VIP21, a component of transport vesicles. FEBS Letters. 1992; 314(1): 45-8. DOI: https://doi.org/10.1016/0014-5793(92)81458-X
Glenney JR Jr, Soppet D. Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts. Proc Natl Acad Sci U S A. 1992; 89(21): 10517-21. DOI: https://doi.org/10.1073/pnas.89.21.10517
Altshuler DM, Gibbs RA, Peltonen L, Altshuler DM, Gibbs RA, Peltonen L, et al. Integrating common and rare genetic variation in diverse human populations. Nature. 2010; 467(7311): 52-8. DOI: https://doi.org/10.1038/nature09298
Martin S. Caveolae, lipid droplets, and adipose tissue biology: pathophysiological aspects. Horm Mol Biol Clin Investig. 2013; 15(1): 11-8. DOI: https://doi.org/10.1515/hmbci-2013-0035
Kandror KV, Stephens JM, Pilch PF. Expression and compartmentalization of caveolin in adipose cells: coordinate regulation with and structural segregation from GLUT4. J Cell Biol. 1995; 129(4): 999-1006. DOI: https://doi.org/10.1083/jcb.129.4.999
Scherer PE, Lisanti MP, Baldini G, Sargiacomo M, Mastick CC, Lodish HF. Induction of caveolin during adipogenesis and association of GLUT4 with caveolin-rich vesicles. J Cell Biol. 1994; 127(5): 1233-43. DOI: https://doi.org/10.1083/jcb.127.5.1233
Shi XE, Li YF, Jia L, Ji HL, Song ZY, Cheng J, et al. MicroRNA-199a-5p affects porcine preadipocyte proliferation and differentiation. Int J Mol Sci. 2014; 15(5) :8526-38. DOI: https://doi.org/10.3390/ijms15058526
Karlsson M, Thorn H, Danielsson A, Stenkula KG, Ost A, Gustavsson J, et al. Colocalization of insulin receptor and insulin receptor substrate-1 to caveolae in primary human adipocytes. Cholesterol depletion blocks insulin signalling for metabolic and mitogenic control. European J Biochem. 2004; 271(12): 2471-9. DOI: https://doi.org/10.1111/j.1432-1033.2004.04177.x
Nystrom FH, Chen H, Cong LN, Li Y, Quon MJ. Caveolin-1 interacts with the insulin receptor and can differentially modulate insulin signaling in transfected Cos-7 cells and rat adipose cells. Mol Endocrinol. 1999; 13(12): 2013-24. DOI: https://doi.org/10.1210/mend.13.12.0392
Kimura A, Mora S, Shigematsu S, Pessin JE, Saltiel AR. The insulin receptor catalyzes the tyrosine phosphorylation of caveolin-1. J Biol Chem. 2002; 277(33): 30153-8. DOI: https://doi.org/10.1074/jbc.M203375200
Gonzalez-Munoz E, Lopez-Iglesias C, Calvo M, Palacin M, Zorzano A, Camps M. Caveolin-1 loss of function accelerates glucose transporter 4 and insulin receptor degradation in 3T3-L1 adipocytes. Endocrinology. 2009; 150(8): 3493-502. DOI: https://doi.org/10.1210/en.2008-1520
Pol A, Martin S, Fernandez MA, Ferguson C, Carozzi A, Luetterforst R, et al. Dynamic and regulated association of caveolin with lipid bodies: modulation of lipid body motility and function by a dominant negative mutant. Mol Biol Cell. 2004; 15(1): 99-110. DOI: https://doi.org/10.1091/mbc.e03-06-0368
Ost A, Ortegren U, Gustavsson J, Nystrom FH, Stralfors P. Triacylglycerol is synthesized in a specific subclass of caveolae in primary adipocytes. J Biol Chem. 2005; 280(1): 5-8. DOI: https://doi.org/10.1074/jbc.C400429200
Cohen AW, Razani B, Schubert W, Williams TM, Wang XB, Iyengar P, et al. Role of caveolin-1 in the modulation of lipolysis and lipid droplet formation. Diabetes. 2004; 53(5): 1261-70. DOI: https://doi.org/10.2337/diabetes.53.5.1261
Briand N, Prado C, Mabilleau G, Lasnier F, Le Liepvre X, Covington JD, et al. Caveolin-1 expression and cavin stability regulate caveolae dynamics in adipocyte lipid store fluctuation. Diabetes. 2014; 63(12): 4032-44. DOI: https://doi.org/10.2337/db13-1961
Razani B, Combs TP, Wang XB, Frank PG, Park DS, Russell RG, et al. Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities. J Biol Chem. 2002; 277(10): 8635-47. DOI: https://doi.org/10.1074/jbc.M110970200
Grilo A, Fernandez ML, Beltran M, Ramirez-Lorca R, Gonzalez MA, Royo JL, et al. Genetic analysis of CAV1 gene in hypertension and metabolic syndrome. Thromb Haemost. 2006; 95(4): 696-701. DOI: https://doi.org/10.1160/TH05-10-0699
Baudrand R, Goodarzi MO, Vaidya A, Underwood PC, Williams JS, Jeunemaitre X, et al. A prevalent caveolin-1 gene variant is associated with the metabolic syndrome in Caucasians and Hispanics. Metabolism: clinical and experimental. 2015; 64(12):1674-81. DOI: https://doi.org/10.1016/j.metabol.2015.09.005
Pojoga LH, Underwood PC, Goodarzi MO, Williams JS, Adler GK, Jeunemaitre X, et al. Variants of the caveolin-1 gene: a translational investigation linking insulin resistance and hypertension. J Clin Endocrinol Metab. 2011; 96(8): e1288-92. DOI: https://doi.org/10.1210/jc.2010-2738
Yamada Y, Ando F, Shimokata H. Association of gene polymorphisms with blood pressure and the prevalence of hypertension in community-dwelling Japanese individuals. Int J Mol Med. 2007; 19(4): 675-83. DOI: https://doi.org/10.3892/ijmm.19.4.675
Michal G. Biochemical pathways: an atlas of biochemistry and molecular biology: Wiley; 1999.
Feingold KR, Grunfeld C. Obesity and Dyslipidemia. In: De Groot LJ, Beck-Peccoz P, Chrousos G, Dungan K, Grossman A, Hershman JM, et al. Endotext. South Dartmouth (MA); MDText.com, Inc.; 2000.
World Health Organization. Global status report on noncommunicable diseases 2014. Geneva: World Health Organization; 2014. 280 p. p.
Patino-Villada FA, Arango-Velez EF, Quintero-Velasquez MA, Arenas-Sosa MM. Factores de riesgo cardiovascular en una población urbana de Colombia. Rev Salud Publica. 2011; 13(3): 433-45.
Davila EP, Quintero MA, Orrego ML, Ford ES, Walke H, Arenas MM, et al. Prevalence and risk factors for metabolic syndrome in Medellin and surrounding municipalities, Colombia, 2008-2010. Prev Med. 2013; 56(1): 30-4. DOI: https://doi.org/10.1016/j.ypmed.2012.10.027
Mora Garcia G, Gomez-Camargo D, Mazenett E, Alario Bello A, Fortich A, Gomez Alegria C. Anthropometric parameters’ cut-off points and predictive value for metabolic syndrome in women from Cartagena, Colombia. Salud Publica Mex. 2014; 56(2): 146-53. DOI: https://doi.org/10.21149/spm.v56i2.7330
Mora Garcia G, Salguedo Madrid G, Ruiz Diaz M, Ramos Clason E, Alario Bello A, Fortich A, et al. Concordancia entre cinco definiciones de síndrome metabólico. Cartagena, Colombia. Rev Española Salud Publica. 2012; 86(3): 301-11. DOI: https://doi.org/10.1590/S1135-57272012000300009
Gomez Camargo D, Camacho-Mejorado R, Gomez Alegria C, Alario Bello A, Hernandez-Tobias EA, Mora Garcia G, et al. Genetic structure of Cartagena de Indias population using hypervariable markers of Y chromosome. Open J Gen. 2015; 5(1): 1-20.
Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009; 120(16): 1640-5. DOI: https://doi.org/10.1161/CIRCULATIONAHA.109.192644
Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16(3): 1215. DOI: https://doi.org/10.1093/nar/16.3.1215
de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies. Nat Genet. 2005; 37(11): 1217-23. DOI: https://doi.org/10.1038/ng1669
Excoffier L, Lischer HE. Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows. Mol Ecol Resour. 2010; 10(3): 564-7. DOI: https://doi.org/10.1111/j.1755-0998.2010.02847.x
Clarke GM, Anderson CA, Pettersson FH, Cardon LR, Morris AP, Zondervan KT. Basic statistical analysis in genetic case-control studies. Nature Protocols. 2011; 6(2): 121-33. DOI: https://doi.org/10.1038/nprot.2010.182
National Center For Biotechnology Information. dbSNP Short Genetic Variations. 2016. Available from: http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1049337.
Rheals A, Flórez-Bolívar F. Entre lo Árabe y lo Negro: Raza e Inmigración en Cartagena, 1880-1930. Rev Sociedad Econom. 2008(15): 123-44. DOI: https://doi.org/10.25100/sye.v0i15.4091
Noguera MC, Schwegler A, Gomes V, Briceno I, Alvarez L, Uricoechea D, et al. Colombia´s racial crucible: Y chromosome evidence from six admixed communities in the Department of Bolivar. Ann Hum Biol. 2014; 41(5): 453-9. DOI: https://doi.org/10.3109/03014460.2013.852244
Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, von Elm E, et al. Strengthening the Reporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Med. 2009; 6(2):e22. DOI: https://doi.org/10.1371/journal.pmed.1000022
Lasso M. Race War and Nation in Caribbean Gran Colombia, Cartagena, 1810-1832. Am Historical Rev. 2006; 111(2): 336-61. DOI: https://doi.org/10.1086/ahr.111.2.336
Lemaitre E, Herazo DB, Patrón FS. Historia general de Cartagena: Banco de la República: Bogotá; 1983. 714 p.
Múnera A, Molina LF. El fracaso de la nación: región, clase y raza en el Caribe colombiano (1717-1821): Banco de la República & El Ancora Editores: Bogotá; 1998. 253 p.
Goncalves VF, Prosdocimi F, Santos LS, Ortega JM, Pena SD. Sex-biased gene flow in African Americans but not in American Caucasians. Genet Mol Res. 2007; 6(2): 256-61.
Simms TM, Wright MR, Martinez E, Regueiro M, McCartney Q, Herrera RJ. Y-STR diversity and sex-biased gene flow among Caribbean populations. Gene. 2013; 516(1): 82-92.. DOI: https://doi.org/10.1016/j.gene.2012.11.006
Downloads
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use